These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 22995409)
21. To Become or Not to Become Tumorigenic: Subventricular Zone Fontán-Lozano Á; Morcuende S; Davis-López de Carrizosa MA; Benítez-Temiño B; Mejías R; Matarredona ER Front Oncol; 2020; 10():602217. PubMed ID: 33330101 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779 [TBL] [Abstract][Full Text] [Related]
23. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression. Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848 [TBL] [Abstract][Full Text] [Related]
30. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties. Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656 [TBL] [Abstract][Full Text] [Related]
31. CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component. Kahlert UD; Bender NO; Maciaczyk D; Bogiel T; Bar EE; Eberhart CG; Nikkhah G; Maciaczyk J Folia Neuropathol; 2012; 50(4):357-68. PubMed ID: 23319191 [TBL] [Abstract][Full Text] [Related]
32. [Characteristics of morphology, differentiation related marker, and proliferation dynamics of differentiated brain tumor stem cells in vitro]. Ji XY; Huang Q; Dong J; Zhu YD; Wang AD; Lan Q Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(23):1604-9. PubMed ID: 16854298 [TBL] [Abstract][Full Text] [Related]
33. [Progress in the study of brain tumor stem cells as treatment targets]. Hide T; Kuratsu J Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855 [TBL] [Abstract][Full Text] [Related]
34. Tropism of mesenchymal stem cell toward CD133 Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179 [TBL] [Abstract][Full Text] [Related]
35. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
36. Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? Behrooz AB; Syahir A Front Oncol; 2021; 11():642719. PubMed ID: 33869033 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Lottaz C; Beier D; Meyer K; Kumar P; Hermann A; Schwarz J; Junker M; Oefner PJ; Bogdahn U; Wischhusen J; Spang R; Storch A; Beier CP Cancer Res; 2010 Mar; 70(5):2030-40. PubMed ID: 20145155 [TBL] [Abstract][Full Text] [Related]
38. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme. Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043 [TBL] [Abstract][Full Text] [Related]
39. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. deCarvalho AC; Nelson K; Lemke N; Lehman NL; Arbab AS; Kalkanis S; Mikkelsen T Stem Cells; 2010 Feb; 28(2):181-90. PubMed ID: 19937755 [TBL] [Abstract][Full Text] [Related]
40. An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells. Gil-Ranedo J; Mendiburu-Eliçabe M; García-Villanueva M; Medina D; del Álamo M; Izquierdo M PLoS One; 2011; 6(12):e28753. PubMed ID: 22174890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]